CELL INTELLIGENCE · 肿瘤细胞治疗研究

间充质干细胞介导的递送提升基于逆转录病毒复制载体的自杀基因治疗在腹膜播散性癌症中的疗效

Mesenchymal stem cell-mediated delivery boosts the efficacy of suicide gene therapy based on retroviral replicating vectors in peritoneally disseminat

肿瘤特异性抗人平足蛋白抗体 chLpMab-2f 对胸膜间皮瘤的抗肿瘤作用

Cancer-Specific Antihuman Podoplanin Antibody chLpMab-2f Exerts Antitumor Effects Against Pleural Mesothelioma.

通过替换连接序列改善自激活嵌合抗原受体的功能

Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequence.

间皮瘤治疗的最新进展：免疫治疗、先进细胞疗法及其他创新治疗模式

Recent Advances in Mesothelioma Treatment: Immunotherapy, Advanced Cell Therapy, and Other Innovative Therapeutic Modalities.

通过层次聚类分析利用肿瘤微环境中的免疫细胞对胸膜间皮瘤进行特征描述

Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment.

我们的发现表明，针对 CD70-CD27 和/或 CD47-SIRPA 轴的免疫检查点及/或免疫细胞靶向疗法，可根据 PM 患者的肿瘤免疫微环境特征，与 PD-L1-PD-1 靶向疗法联合应用于这些患者。

靶向恶性间皮瘤特异性抗原唾液酸化 HEG1 的新型嵌合抗原受体表达 T 细胞

Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.

抗平足蛋白抗体通过 NK 细胞增强 CTLA-4 阻断对恶性间皮瘤的抗肿瘤作用

Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells.

LAG3 是恶性胸膜间皮瘤的独立预后生物标志物和免疫检查点抑制剂的潜在靶点：一项回顾性研究

LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective s

LAG3 表达与多种癌症的预后相关，尤其是 MPM；LAG3 是 MPM 的独立预后生物标志物。LAG3 调节癌症免疫，是 ICIs 治疗的潜在靶点。PD-1 和 LAG3 抑制剂可能有助于改善 MPM 的预后。

日本血凝病毒包膜联合化疗或免疫检查点抑制剂对恶性胸膜间皮瘤的附加效应：一项体内研究

Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothel

肿瘤浸润 CD8+ T 细胞、PD1/PD-L1 轴及 HLA I 类表达模式对接受胸膜外全肺切除术的恶性胸膜间皮瘤患者预后的影响

Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural